Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of lysine demethylation and oxidative phosphorylation
Preprint in bioRxiv (November 2023)
The most recent citing publications are shown below. View all 33 publications that cite this research output on Dimensions.
Preprint in bioRxiv (November 2023)
Article in Pharmacology & Therapeutics (September 2023)
Article in Brain Sciences (July 2023)